Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway

Fig. 4

Effects of amygdalin on HepG2.2.15 cell viability, apoptosis, invasion, and migration. a-d HepG2.2.15 cells were co-cultured with NC-T, HBV-T cells or amygdalin treated HBV-T cells and examined for the cell viability, apoptosis, caspase-3 cleavage, invasion, and migration of HepG2.2.15 cells using MTT (a), Flow cytometry (b), immunoblotting (c), and Transwell assays (d, e) n = 5 for MTT assay, n = 3 for flow cytometry, transwell assays and immunoblotting. *p < 0.05, **p < 0.01, compared to HepG2.2.15 + NC-T group, #p < 0.05, ##p < 0.01, compared to HepG2.2.15 + HBV-T group

Back to article page